Live Chat

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2024 Nov 20, 11:25

What is B. Riley's Forecast for Novavax FY2024 Earnings?

Novavax Inc
Webhose 2024 Nov 19, 06:52

FY2024 Earnings Forecast for Novavax Issued By HC Wainwright

Novavax Inc
Webhose 2024 Nov 18, 13:06

Novavax stock outlook updated as strategic shift emphasizes adjuvant-enabled candidates By Investing.com

Novavax Inc
Webhose 2024 Nov 18, 06:50

FY2024 EPS Estimates for Novavax Decreased by HC Wainwright

Novavax Inc
Webhose 2024 Nov 16, 06:20

HC Wainwright Estimates Novavax’s Q3 Earnings (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 15, 18:16

Health Stocks (MRNA, PFE) Plunge After Vaccine Skeptic RFK Named Trump's Appointment of Vaccine Skeptic RFK - Markets Insider

Novavax Inc
Webhose 2024 Nov 15, 17:31

Pharma Stocks Take Nose Dive After Trump Announces RFK Jr. For HHS

Novavax Inc
Webhose 2024 Nov 15, 12:47

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | Morningstar

Novavax Inc
Webhose 2024 Nov 15, 11:29

Novavax (NASDAQ:NVAX) Releases Earnings Results, Beats Estimates By $0.11 EPS

Novavax Inc
Webhose 2024 Nov 14, 18:12

Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS

Novavax Inc
Webhose 2024 Nov 14, 13:17

What is HC Wainwright's Estimate for Novavax Q3 Earnings?

Novavax Inc
Webhose 2024 Nov 14, 00:00

Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - November 14, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 13, 22:57

Health Care Down as Vaccine Makers Slide — Health Care Roundup | Morningstar

Novavax Inc
Webhose 2024 Nov 13, 14:08

Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS

Novavax Inc
Webhose 2024 Nov 13, 13:55

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript

Novavax Inc
Webhose 2024 Nov 13, 07:08

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...

Novavax Inc
Webhose 2024 Nov 13, 00:00

Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - November 13, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 13, 00:00

Novavax Inc (NVAX) - Insider Monkey

Novavax Inc
Webhose 2024 Nov 12, 14:04

Novavax's (NVAX) Buy Rating Reaffirmed at HC Wainwright

Novavax Inc
Webhose 2024 Nov 12, 12:33

Novavax Cuts FY24 Revenue View Below Market; Stock Drops In Pre-market - Update

Novavax Inc
Webhose 2024 Nov 12, 12:06

Novavax Inc. Q3 Loss Decreases, Beats Estimates

Novavax Inc
Webhose 2024 Nov 12, 05:21

Novavax earnings beat by $0.07, revenue topped estimates By Investing.com

Novavax Inc
Webhose 2024 Nov 12, 05:05

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales By Reuters

Novavax Inc
Webhose 2024 Nov 12, 02:46

Novavax shares tumble 11% as revenue guidance disappoints By Investing.com

Novavax Inc
Webhose 2024 Nov 12, 00:00

Novavax's stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss | Morningstar

Novavax Inc
Webhose 2024 Nov 12, 00:00

NovaVax's stock slides 7% as lowered guidance offsets narrower-than-expected Q3 loss | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 21:06

Continuation of Trump Trade takes Dollar to multi-month highs - Newsquawk US Market Wrap

Novavax Inc
Webhose 2024 Nov 11, 17:49

Novavax (NASDAQ:NVAX) Shares Gap Up - Should You Buy?

Novavax Inc
Webhose 2024 Nov 11, 15:34

Novavax Target of Unusually High Options Trading (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 11, 15:03

Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold — Update | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 14:05

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 14:02

FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up

Novavax Inc
Webhose 2024 Nov 11, 13:36

Novavax’s Clinical Hold on Covid, Flu Combo Trial Cleared by FDA

Novavax Inc
Webhose 2024 Nov 11, 13:30

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial | Morningstar

Novavax Inc
Webhose 2024 Nov 11, 13:05

FDA Lifts Hold on Novavax's Combo COVID-Flu Shot

Novavax Inc
Webhose 2024 Nov 11, 05:57

Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot By Investing.com

Novavax Inc
Webhose 2024 Nov 11, 00:00

Novavax to Report Q3 Earnings: Here's What to Expect - November 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 11, 00:00

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? - November 11, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Nov 07, 08:52

Nisa Investment Advisors LLC Has $296,000 Position in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2024 Nov 05, 20:42

Novavax (NVAX) Scheduled to Post Quarterly Earnings on Tuesday

Novavax Inc
Webhose 2024 Nov 05, 07:44

Vanguard Group Inc's Strategic Acquisition of Novavax Inc Shares

Novavax Inc
Webhose 2024 Nov 04, 21:30

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 | Morningstar

Novavax Inc
Webhose 2024 Nov 04, 07:05

Novavax, Inc. (NASDAQ:NVAX) Given Consensus Recommendation of “Hold” by Brokerages

Novavax Inc
Webhose 2024 Nov 04, 07:05

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts

Novavax Inc
Webhose 2024 Oct 30, 12:57

A Game-Changing Vaccine

Novavax Inc
Webhose 2024 Oct 29, 00:00

Novavax (NVAX) Stock Dips While Market Gains: Key Facts - October 29, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 27, 20:00

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm | Morningstar

Novavax Inc
Webhose 2024 Oct 26, 12:10

Sanofi (NASDAQ:SNY) Q3 2024 Earnings Call Transcript

Novavax Inc
Webhose 2024 Oct 25, 15:00

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX | Morningstar

Novavax Inc
Webhose 2024 Oct 25, 13:12

Earnings call: Sanofi reports robust Q3 sales and raises 2024 EPS guidance By Investing.com

Novavax Inc
Webhose 2024 Oct 23, 00:00

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note - October 23, 2024 - Zacks.com

Novavax Inc
Webhose 2024 Oct 22, 18:09

Q&A on the 2024-2025 COVID-19 Vaccines

Novavax Inc

Latest news

Frances Wang 2024 Nov 20, 16:00

MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K

Cryptocurrencies
Frances Wang 2024 Nov 20, 16:00

Nasdaq futures decline, Nvidia shares dip following the earnings report

Indices CFD Trading Stocks
Mixed market performance
Neil Wilson 2024 Nov 20, 16:00

Markets Mixed Amid Inflation, Tech Rally, and UK Economic Woes

USD Tech S&P 500
Frances Wang 2024 Nov 19, 16:00

Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024

NVDA Stocks
Frances Wang 2024 Nov 19, 16:00

Bitcoin price hits record high over $93,800 as Trump rally resumes

Cryptocurrencies
Rising gold prices
Neil Wilson 2024 Nov 19, 16:00

Gold Shines, Bitcoin Surges, and Nvidia Earnings in Focus

Gold Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

What is the cryptocurrency market doing: Musk's DOGE Role Boosts Dogecoin

Cryptocurrencies
Frances Wang 2024 Nov 18, 16:00

Bitcoin price prediction: BTC May Reach $100K Before New Year

Cryptocurrencies

Info

Spread

0.05

Spread (%)

0.6211 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1291091072

Shares Outstanding

160184992

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2.18

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat